Sclerotherapy in the Treatment of Familial Disseminated Cutaneous Glomuvenous Malformations: Case Report

Glomuvenous malformations usually present as soft bluish-purple dermal or subcutaneous papules, nodules or plaques, and can occur as sporadic or inherited lesions. We present the case of a 41-year-old female, referred for evaluation of disseminated bluish lesions developing since puberty. Histopatho...

Full description

Saved in:
Bibliographic Details
Main Authors: Francisco Gil (Author), Santiago Ortiz (Author), João Aranha (Author)
Format: Book
Published: Sociedade Portuguesa de Dermatologia e Venereologia, 2019-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_97fa294e66a943e2b5fac30be7c5d4bc
042 |a dc 
100 1 0 |a Francisco Gil  |e author 
700 1 0 |a Santiago Ortiz  |e author 
700 1 0 |a João Aranha  |e author 
245 0 0 |a Sclerotherapy in the Treatment of Familial Disseminated Cutaneous Glomuvenous Malformations: Case Report 
260 |b Sociedade Portuguesa de Dermatologia e Venereologia,   |c 2019-10-01T00:00:00Z. 
500 |a 10.29021/spdv.77.3.1087 
500 |a 2182-2395 
500 |a 2182-2409 
520 |a Glomuvenous malformations usually present as soft bluish-purple dermal or subcutaneous papules, nodules or plaques, and can occur as sporadic or inherited lesions. We present the case of a 41-year-old female, referred for evaluation of disseminated bluish lesions developing since puberty. Histopathology was consistent with the diagnosis of glomuvenous malformations. The history of a sister with similar lesions justified a genetic study of the glomulin gene that revealed a pathogenic mutational variant allowing the diagnosis of familial disseminated cutaneous glomuvenous malformations. Whereas surgical management is often used for symptomatic solitary lesions of glomuvenous malformations, other treatment modalities have been reported for treatment of multiple lesions, with variable results. The patient underwent sclerotherapy with polidocanol and there were significant symptomatic and cosmetic improvements after six sessions, with no adverse effects and no recurrence after 6 months. 
546 |a EN 
546 |a PT 
690 |a Glomus Tumor/genetics 
690 |a Glomus Tumor/therapy 
690 |a Sclerotherapy 
690 |a Skin Neoplasms 
690 |a Dermatology 
690 |a RL1-803 
690 |a Infectious and parasitic diseases 
690 |a RC109-216 
655 7 |a article  |2 local 
786 0 |n Revista da Sociedade Portuguesa de Dermatologia e Venereologia, Vol 77, Iss 3 (2019) 
787 0 |n https://revista.spdv.com.pt/index.php/spdv/article/view/1087 
787 0 |n https://doaj.org/toc/2182-2395 
787 0 |n https://doaj.org/toc/2182-2409 
856 4 1 |u https://doaj.org/article/97fa294e66a943e2b5fac30be7c5d4bc  |z Connect to this object online.